Invesco Portfolio holdings
Invesco is an investment management company that launched the Invesco QQQ exchange-traded fund in 1999, back when it operated as Amvescap. Invesco QQQ tracks the Nasdaq-100 index of companies listed on Nasdaq. Invesco traces its roots to H. Lotery & Co., a UK advisory firm formed in 1935, and in 1978 Charles Brady and eight partners bought the money management arm of Citizens & Southern National Bank, then called INVESCO. It bought PowerShares Capital Management, sponsor of 36 exchange-traded funds, in 2006, and in 2007 it went back to the Invesco name and moved its legal home to Bermuda. Its 2009 purchase of Morgan Stanley's retail unit brought in Van Kampen Investments, and in 2019 it acquired OppenheimerFunds from Massachusetts Mutual Life Insurance Company. It serves retail and institutional investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$6.35B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$2.84B |
| 3 |
Arm
ARM
|
+$1.84B |
| 4 |
Lumentum
LITE
|
+$1.78B |
| 5 |
Teradyne
TER
|
+$1.57B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco NASDAQ 100 ETF
QQQM
|
+$2.26B |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.2B |
| 3 |
Honeywell
HON
|
+$2.2B |
| 4 |
Dell
DELL
|
+$1.69B |
| 5 |
Insmed
INSM
|
+$744M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.02% |
| 2 | Consumer Discretionary | 9.35% |
| 3 | Communication Services | 9.23% |
| 4 | Industrials | 8.62% |
| 5 | Healthcare | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2451
Natural Gas Services Group
NGS
$418M
| $2.41M | ﹤0.01% |
55,943
+4,177
| +8% | +$170K |
2024 Q1
9 quarters
|
|
2452
BNY Mellon High Yield Strategies Fund
DHF
$164M
| $2.4M | ﹤0.01% |
993,218
+25,523
| +3% | +$61.8K |
2013 Q2
52 quarters
|
|
2453
Celcuity
CELC
$3.38B
| $2.4M | ﹤0.01% |
22,952
-68,024
| -75% | -$7.85M |
2025 Q3
3 quarters
|
|
2454
Live Oak Bancshares
LOB
$1.6B
| $2.4M | ﹤0.01% |
58,742
-6,539
| -10% | -$244K |
2018 Q1
33 quarters
|
|
2455
Hamilton Insurance Group
HG
$3.45B
| $2.4M | ﹤0.01% |
70,568
+12,127
| +21% | +$380K |
2024 Q4
6 quarters
|
|
2456
Hovnanian Enterprises
HOV
$592M
| $2.39M | ﹤0.01% |
16,815
-1,477
| -8% | -$169K |
2013 Q2
52 quarters
|
|
2457
Oxford Industries
OXM
$422M
| $2.39M | ﹤0.01% |
68,569
-119,593
| -64% | -$4.97M |
2013 Q2
52 quarters
|
|
2458
Cerence
CRNC
$366M
| $2.39M | ﹤0.01% |
210,693
-48,775
| -19% | -$478K |
2019 Q4
26 quarters
|
|
2459
AtriCure
ATRC
$3.12B
| $2.37M | ﹤0.01% |
84,847
+7,531
| +10% | +$212K |
2017 Q1
37 quarters
|
|
2460
Invesco BulletShares 2034 Municipal Bond ETF
BSMY
$165M
| $2.37M | ﹤0.01% |
96,218
+2,030
| +2% | +$49.8K |
2024 Q4
6 quarters
|
|
2461
Core Laboratories
CLB
$488M
| $2.35M | ﹤0.01% |
202,140
-29,861
| -13% | -$426K |
2013 Q2
52 quarters
|
|
2462
Caris Life Sciences
CAI
$9.7B
| $2.35M | ﹤0.01% |
132,103
-1,090,175
| -89% | -$19.5M |
2025 Q2
4 quarters
|
|
2463
Empire State Realty Trust
ESRT
$860M
| $2.35M | ﹤0.01% |
434,064
-17,460
| -4% | -$95K |
2013 Q4
50 quarters
|
|
2464
Monte Rosa Therapeutics
GLUE
$918M
| $2.35M | ﹤0.01% |
97,013
-5,184
| -5% | -$98K |
2024 Q4
6 quarters
|
|
2465
Invesco BulletShares 2033 Municipal Bond ETF
BSSX
$151M
| $2.35M | ﹤0.01% |
90,969
+1,906
| +2% | +$48.9K |
2023 Q4
10 quarters
|
|
2466
John Hancock Preferred Income Fund II
HPF
$279M
| $2.34M | ﹤0.01% |
147,402
-1,051
| -0.7% | -$16.7K |
2013 Q2
52 quarters
|
|
2467
Kenon Holdings
KEN
$3.34B
| $2.34M | ﹤0.01% |
34,966
-6,623
| -16% | -$542K |
2022 Q1
17 quarters
|
|
2468
DoubleLine Opportunistic Credit Fund
DBL
$269M
| $2.34M | ﹤0.01% |
162,442
+4,132
| +3% | +$59.5K |
2013 Q2
52 quarters
|
|
2469
iShares Core S&P Mid-Cap ETF
IJH
$123B
| $2.32M | ﹤0.01% |
30,120
+4,711
| +19% | +$346K |
2013 Q2
52 quarters
|
|
2470
ZTO Express
ZTO
$15B
| $2.31M | ﹤0.01% |
103,135
-21,591
| -17% | -$514K |
2017 Q1
37 quarters
|
|
2471
HealthStream
HSTM
$1.03B
| $2.3M | ﹤0.01% |
84,476
-93,203
| -52% | -$2.18M |
2013 Q2
52 quarters
|
|
2472
Braze
BRZE
$5.2B
| $2.29M | ﹤0.01% |
105,652
-9,725
| -8% | -$217K |
2023 Q1
13 quarters
|
|
2473
Douglas Dynamics
PLOW
$911M
| $2.28M | ﹤0.01% |
42,229
-1,687
| -4% | -$77.8K |
2013 Q2
52 quarters
|
|
2474
Invesco BulletShares 2027 High Yield Corporate Bond ETF
BSJR
$941M
| $2.27M | ﹤0.01% |
101,783
-10,021
| -9% | -$225K |
2024 Q3
7 quarters
|
|
2475
Evolent Health
EVH
$486M
| $2.25M | ﹤0.01% |
414,582
-29,342
| -7% | -$112K |
2016 Q3
39 quarters
|
|
Similar funds
Invesco's Q2 2026 Portfolio in Review
As of Q2 2026, Invesco held 3,969 positions worth $1.26T, up 23% from $1.02T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Invesco's Q2 2026 filing shows 214 new, 1,806 increased, 1,705 reduced and 150 closed positions. Its largest new stake was Honeywell Aerospace: 12,884,435 shares worth $2.85B. The largest sale was Invesco NASDAQ 100 ETF, an estimated $2.26B.
By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Invesco's largest Q2 2026 buy was Honeywell Aerospace: 12,884,435 shares worth $2.85B.
- Invesco added most to Sandisk in Q2 2026, an estimated $6.35B increase.
- Invesco's biggest Q2 2026 reduction was Invesco NASDAQ 100 ETF, cutting an estimated $2.26B.
- Invesco fully exited Coterra Energy in Q2 2026, selling an estimated $394M.
- Invesco's ten largest holdings make up 29% of its $1.26T portfolio in Q2 2026.
- Invesco opened 214 new positions and closed 150 in Q2 2026.
- Invesco's portfolio value rose 23% quarter-over-quarter to $1.26T.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.